Peter

The macroeconomics of liquidity in financial intermediation

Retrieved on: 
Dienstag, Mai 28, 2024
NBT, Yahoo!, E41, Private, Treasury, Interest, Social science, BAA, VIX, GDP, DF, American Economic Journal, Working, NBER, Credit, Great Recession, Calibration, Samsung Galaxy Note 4, Quantitative, Bankruptcy, American Economic Review, Central bank, Paper, Half-life, Business, ZT, Appendix, De Young, Macroprudential regulation, Silicon, Federal Reserve Bank, ESCB, Journal, G21, RBC, United States Treasury security, Failure, TFP, Tax, Kuttner, University, BHT, Journal of Economic Perspectives, ROE, Floor, ICUS, Macroeconomics, Empiricism, Knowledge, Economy, Aggregate demand, Process control block, University of Bern, OLS, Risk, Monetary economics, Rochet, PCE, Research Papers in Economics, Real, EEA, Congress, Quarterly Journal, Depreciation, Mark Gertler, Welfare, ECB, Labour, Friction, Reproduction, CUSIP, Sale, Convention (norm), Complementarity, Capital, Liskov substitution principle, Financial intermediary, Financial Crisis Inquiry Commission, Timeline, Finance, COVID-19, Peter, Bank failure, Ahnert, Policy, DNT, Website, Political economy, Working paper, Cobb–Douglas production function, Intermediation, LH, Government, Van de Weyer, TED, The Journal of Finance, Fear, Probability, Addiction, Observation, Elasticity, Noise, National bank, QT, Leverage, E51, JEL, Household, Interval (mathematics), Journal of Economic Theory, Conference, Monetary policy, London School of Economics, Shock, Proposition 1, Linearity, RHS, Use, Durham University, Uncertainty, Journal of Political Economy, Funding, Intuition, Quarterly Journal of Economics, Note 2, Bank regulation, AB, FST, EDS, Carlsson, FDIC, Motion, PDF, Loanable funds, Holding, XT, G01, FRED, Creditor, Partial, European Economic Association, N,N-Dimethyltryptamine, CHT, TGA, MB, Nash, Macroeconomic model, JT, Federal, Movement, JB, Wealth, DTS, Face, Outline, Fragility, European Central Bank, HBT, Business cycle, Literature, QE, Xavier Vives, Research, GC, Samsung Galaxy Note 3, Federal Deposit Insurance Corporation, Data, Heart, Shin, Quantitative easing, Bianchi, Acquisition, Logic, Bank
Key Points: 

    Peter Eckes, Former CTO of BASF Agricultural Solutions, to Chair Harpe Bioherbicide Board

    Retrieved on: 
    Mittwoch, April 17, 2024
    Congress, Peter, University, UN, Seed, University of Western Australia, Eckes, BASF, Organic, North Carolina State University, Life, Farmer, Desiccation, Crop protection, Weed control, Associate, World Congress, Harpe, Management

    RESEARCH TRIANGLE PARK, N.C., April 17, 2024 /PRNewswire/ -- Harpe Bioherbicide Solutions, Inc., an agricultural technology company focused on providing natural and sustainable herbicide solutions, announced today that Dr. Peter Eckes, former President of BASF leading Crop Protection R&D, Seed and Trait R&D and Regulatory in the Agricultural Solutions division, has joined its board and will serve as board chairperson.

    Key Points: 
    • "Harpe has both a compelling value proposition and strong business plan to bring new and natural weed control innovations to life," said Eckes.
    • Eckes assumes board leadership from Aidan J. Connolly, President of AgriTech Capital, who will remain as a Harpe Bioherbicide board member.
    • Additional Harpe Bioherbicide board members include CEO Buckner; Kip Tom, CEO of Tom Farms and former UN Ambassador; Robb Fraley, former CTO for Monsanto Co.; Chad Brommer, Harpe Bioherbicide co-founder and CTO; and Daniel Pepitone, Harpe Bioherbicide co-founder and COO.
    • Those attending are invited to visit Booth #22 to learn more about Harpe Bioherbicide formulations.

    Peter Eckes, Former CTO of BASF Agricultural Solutions, to Chair Harpe Bioherbicide Board

    Retrieved on: 
    Mittwoch, April 17, 2024
    Congress, Peter, University, UN, Seed, University of Western Australia, Eckes, BASF, Organic, North Carolina State University, Life, Farmer, Desiccation, Crop protection, Weed control, Associate, World Congress, Harpe, Management

    RESEARCH TRIANGLE PARK, N.C., April 17, 2024 /PRNewswire/ -- Harpe Bioherbicide Solutions, Inc., an agricultural technology company focused on providing natural and sustainable herbicide solutions, announced today that Dr. Peter Eckes, former President of BASF leading Crop Protection R&D, Seed and Trait R&D and Regulatory in the Agricultural Solutions division, has joined its board and will serve as board chairperson.

    Key Points: 
    • "Harpe has both a compelling value proposition and strong business plan to bring new and natural weed control innovations to life," said Eckes.
    • Eckes assumes board leadership from Aidan J. Connolly, President of AgriTech Capital, who will remain as a Harpe Bioherbicide board member.
    • Additional Harpe Bioherbicide board members include CEO Buckner; Kip Tom, CEO of Tom Farms and former UN Ambassador; Robb Fraley, former CTO for Monsanto Co.; Chad Brommer, Harpe Bioherbicide co-founder and CTO; and Daniel Pepitone, Harpe Bioherbicide co-founder and COO.
    • Those attending are invited to visit Booth #22 to learn more about Harpe Bioherbicide formulations.

    Peter McGoldrick Joins Alliant Insurance Services, Serves Power Generation Client Base

    Retrieved on: 
    Mittwoch, März 27, 2024
    Insurance, Professional Services, Fairfield University, Negotiation, Risk management, Liberty Mutual, Risk, History, Peter, Alliant, Hofstra University, P&C, McGoldrick, Economics

    Peter McGoldrick has joined Alliant Insurance Services as Senior Vice President, Alliant Specialty, in the company’s Tampa, Florida, office.

    Key Points: 
    • Peter McGoldrick has joined Alliant Insurance Services as Senior Vice President, Alliant Specialty, in the company’s Tampa, Florida, office.
    • Drawing upon his extensive 25-year insurance career, McGoldrick focuses on clients who develop, construct and operate thermal and renewable power generation facilities.
    • Over the past 15 years, McGoldrick has helped power generation clients identify, mitigate and manage risk, often serving in an outsourced risk manager capacity, fully integrated into clients’ day-to-day operational teams.
    • “Peter brings extensive and specialized expertise to support the risk management needs of power generation facilities, adding tremendous value for Alliant’s Power clients,” said Rob Bothwell, Managing Director, Alliant Specialty, within the company’s Power vertical.

    Crisp, Clean, and Refreshing: Winsome Ciderworks, Under New Ownership, Ready to Refresh the Northwest

    Retrieved on: 
    Mittwoch, März 20, 2024
    Drink, Acquisition, Peter, Click, Multimedia, Telescopic sight

    WOODINVILLE, Wash. , March 20, 2024 /PRNewswire/ -- Seasoned beverage executives Peter Click, Alan MacDonald, and their families, are excited to announce the acquisition of Winsome Ciderworks in Woodinville, WA. With a combined 5-decades experience in the alcoholic beverage industry, Peter and Alan are thrilled to reintroduce and expand the sales and distribution of Winsome Ciders.

    Key Points: 
    • With a combined 5-decades experience in the alcoholic beverage industry, Peter and Alan are thrilled to reintroduce and expand the sales and distribution of Winsome Ciders.
    • The collaboration of the Click and MacDonald families marks an exciting new chapter in the Winsome story.
    • The initial encounter with Leroy Radford, the founder of Winsome Ciderworks, left a lasting impression on the partners.
    • Keep an eye out for Winsome Ciders at local Northwest retailers and on-premise accounts.

    Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial

    Retrieved on: 
    Dienstag, Februar 27, 2024
    Cancer, Glomus tumor, MD, International Cancer Imaging Society, Society, Therapy, Peter, Patient, Radiopharmaceutical, Molecular imaging, MTIC, MBBS, Pancreatic cancer, Research, PET/CT, Prostate cancer, Medical imaging

    “We are very excited to have Professor Hicks as the lead investigator for our MNPR-101-Zr clinical trial,” said Chandler Robinson, MD, Monopar’s Chief Executive Officer.

    Key Points: 
    • “We are very excited to have Professor Hicks as the lead investigator for our MNPR-101-Zr clinical trial,” said Chandler Robinson, MD, Monopar’s Chief Executive Officer.
    • In 2023, Professor Hicks received the Saul Hertz Award from the Society of Nuclear Medicine and Molecular Imaging for his lifetime contribution to radionuclide therapy.
    • “The preclinical data that Monopar announced on this past Thursday encourages us to translate this class of agents into the clinical domain.
    • MNPR-101-Zr is being developed for cancers with very high unmet medical need, such as pancreatic cancer and triple negative breast cancer,” said Professor Hicks.

    Greenberg Traurig Grows FDA Practice in Phoenix; Adds Peter Arhangelsky

    Retrieved on: 
    Freitag, Februar 16, 2024
    Arkhangelsky, Greenberg Traurig, FTC, FAL, UCL, FDA, OTC, Suffolk University Law School, Food, Dietary supplement, First, Anti-competitive practices, CLRA, Private law, Prochnow, University, Peter, Lanham Act, LLP, Federal Trade Commission, Drink, Education Act, P.C

    PHOENIX, Feb. 15, 2024 /PRNewswire-PRWeb/ -- Global law firm Greenberg Traurig, LLP continues to grow its Health Care & FDA Practice in Arizona with the addition of Peter A. Arhangelsky as shareholder.

    Key Points: 
    • Global law firm Greenberg Traurig, LLP continues to grow its Health Care & FDA Practice in Arizona with the addition of Peter A. Arhangelsky as shareholder
      PHOENIX, Feb. 15, 2024 /PRNewswire-PRWeb/ -- Global law firm Greenberg Traurig, LLP continues to grow its Health Care & FDA Practice in Arizona with the addition of Peter A. Arhangelsky as shareholder.
    • Arhangelsky guides businesses that are regulated by the U.S. Food and Drug Administration (FDA) through both regulatory compliance and litigation matters.
    • Arhangelsky's practice complements that of Justin J. Prochnow , co-chair of the Food, Beverage & Agribusiness Group , who focuses on regulatory matters.
    • "Previously, I worked with Peter as co-counsel on a matter, and I just knew he would be an excellent addition to Greenberg Traurig substantively and culturally," Prochnow said.

    Noyo Strengthens Leadership Team with Key Appointments

    Retrieved on: 
    Dienstag, Februar 13, 2024
    Fintech, Partnership, SAN, Data management, Growth, CPO, Angel, Peter, API, Management

    These appointments bolster Noyo's leadership team and position the company for continued growth in the dynamic landscape of benefits technology.

    Key Points: 
    • These appointments bolster Noyo's leadership team and position the company for continued growth in the dynamic landscape of benefits technology.
    • Noyo is pleased to announce the promotion of Elaina O'Mahoney to the role of Chief Product Officer.
    • "It's both thrilling and a great honor for me to step into the Chief Product Officer role at Noyo," O'Mahoney stated.
    • Noyo is also delighted to announce the promotion of Peter Scarlatta to the position of Chief Technology Officer.

    Lazard Appoints Dan Schulman and Stephen R. Howe Jr. to Its Board of Directors

    Retrieved on: 
    Dienstag, Januar 30, 2024
    Asset Management, Professional Services, Finance, Cisco, Fellow, PayPal, Growth, Financial services, Peter R. Orszag, Sprint Corporation, International economics, LAZ, Partner (business rank), Foreign policy, Peter, Council, Virgin Mobile USA, Ernst & Young, Colgate University, Royal Caribbean, Booking Holdings, Trustee, Liberty Science Center, AT&T, Middlebury College, Cleveland Clinic, American Express, Verizon Communications, Management

    “We are thrilled that Dan and Steve are joining our Board of Directors,” said Peter R. Orszag, Chief Executive Officer and Director, Lazard.

    Key Points: 
    • “We are thrilled that Dan and Steve are joining our Board of Directors,” said Peter R. Orszag, Chief Executive Officer and Director, Lazard.
    • Stephen R. Howe Jr. is a widely respected executive, board member, and financial services, audit, and corporate governance expert.
    • “Lazard serves an important role in the financial services landscape, and it is an honor to serve as a member of its Board of Directors.
    • I look forward to working with Peter and fellow Directors, and leveraging my experience on behalf of the firm,” said Mr. Howe.

    Newmont Strengthens Leadership Team with Appointment of Industry Leader Peter Wexler as Chief Legal Officer

    Retrieved on: 
    Mittwoch, Januar 24, 2024
    Mining, Minerals, Natural Resources, ASX, University, American University, NGT, Peter, Multimedia, Corporation, Financial Times, Law, APC by Schneider Electric, Risk, M&A, Gold, NEM, TSX, Schneider Electric, Risk management, Washington College of Law, Appointment, Engineering, Negotiation, Management

    Newmont Corporation (NYSE: NEM, TSX: NGT, ASX: NEM, PNGX: NEM) today announced the appointment of Peter Wexler as Chief Legal Officer.

    Key Points: 
    • Newmont Corporation (NYSE: NEM, TSX: NGT, ASX: NEM, PNGX: NEM) today announced the appointment of Peter Wexler as Chief Legal Officer.
    • Peter will join Newmont’s Executive Leadership Team and be responsible for leading the company’s legal, compliance and regulatory affairs globally.
    • View the full release here: https://www.businesswire.com/news/home/20240123636145/en/
      Newmont Strengthens Leadership Team with Appointment of Industry Leader Peter Wexler as Chief Legal Officer (Photo: Business Wire)
      Peter is an experienced legal and risk management leader with more than three decades of international knowledge in managing legal, risk, compliance, M&A, antitrust, litigation and corporate governance affairs within the industrial, technology, energy management, engineering, manufacturing, and construction sectors.
    • As Schneider Electric’s Chief Legal Officer, Peter managed the company’s legal, risk management and compliance matters across the globe and directed a team of over 300 professionals in 32 countries.